Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Quanticel describes Brd4 inhibitors

April 30, 2015

Wuhan Innerse introduces diphenylethanes for autoimmune diseases

April 30, 2015

Shanghai Yingli patents PI3Kdelta inhibitors

April 30, 2015

Roche and Genentech present TRPA1 antagonists

April 30, 2015

Bristol-Myers Squibb patents mGlu5 receptor PAMs

April 30, 2015

Istituto Italiano di Tecnologia reports development of Rev-erb inhibitors

April 29, 2015

Glenmark patents ROR-gamma modulators

April 29, 2015

Merck & Co. introduces FFAR1 agonists

April 29, 2015

Kadmon discloses ROCK 2 inhibitors

April 29, 2015

Millenium Pharmaceuticals patents ABCG2 inhibitors

April 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...